AU1219400A - Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease - Google Patents
Methods of screening for risk of proliferative disease and methods for the treatment of proliferative diseaseInfo
- Publication number
- AU1219400A AU1219400A AU12194/00A AU1219400A AU1219400A AU 1219400 A AU1219400 A AU 1219400A AU 12194/00 A AU12194/00 A AU 12194/00A AU 1219400 A AU1219400 A AU 1219400A AU 1219400 A AU1219400 A AU 1219400A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- proliferative disease
- screening
- risk
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G01N33/5758—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10526298P | 1998-10-22 | 1998-10-22 | |
| US60105262 | 1998-10-22 | ||
| PCT/US1999/024695 WO2000023624A1 (en) | 1998-10-22 | 1999-10-21 | Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1219400A true AU1219400A (en) | 2000-05-08 |
Family
ID=22304865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12194/00A Abandoned AU1219400A (en) | 1998-10-22 | 1999-10-21 | Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1219400A (en) |
| WO (1) | WO2000023624A1 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE911115A1 (en) * | 1990-04-10 | 1991-10-23 | Canji Inc | Gene therapy for cell proliferative diseases |
| US5998582A (en) * | 1991-05-16 | 1999-12-07 | Cold Spring Harbor Laboratory | D-type cyclins and uses related thereto |
| US5512473A (en) * | 1993-01-29 | 1996-04-30 | Brent; Roger | Max-interacting proteins and related molecules and methods |
| DE69434470T2 (en) * | 1993-02-09 | 2006-06-22 | The Johns Hopkins University School Of Medicine | NUCLEUS MATRIX PROTEINS |
| US5789184A (en) * | 1993-03-31 | 1998-08-04 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| US5549974A (en) * | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
| US5886186A (en) * | 1995-10-25 | 1999-03-23 | Versicor, Inc. | Synthesis of substituted N-heteroaromatic compounds and methods of use thereof |
-
1999
- 1999-10-21 WO PCT/US1999/024695 patent/WO2000023624A1/en not_active Ceased
- 1999-10-21 AU AU12194/00A patent/AU1219400A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000023624A9 (en) | 2000-09-21 |
| WO2000023624A1 (en) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| AU6528800A (en) | Methods and apparatuses for radiation treatment | |
| AU7264298A (en) | Apparatus and method for the reduction of snoring | |
| AU2092697A (en) | Combinations for treatment of proliferative diseases | |
| AU9040098A (en) | Compounds and method for the prevention and treatment of diabetic retinopathy | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2031700A (en) | Stereotactic apparatus and methods | |
| AU1585999A (en) | Methods for the detection and treatment of disease using a glycosyltransferase | |
| AU3552399A (en) | Recombinant poliovirus for the treatment of cancer | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| AU3596199A (en) | Treatment of celiac disease | |
| AU5042000A (en) | Methods of treating proliferative disorders | |
| AU6330999A (en) | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU1697197A (en) | Immunoconjugate for the treatment of aids | |
| AU5298699A (en) | Dnazymes and methods for treating hpv-related disorders | |
| AU8068198A (en) | Methods for treating human cancers | |
| IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
| IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
| AU1710001A (en) | Method and arrangement for determining suitable treatment frequency and/or intensity | |
| AU4480997A (en) | Screening methods for compounds useful in the treatment of schizophrenia | |
| AU5855899A (en) | Method for identifying substances for the treatment of c-jun-mediated disorders | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| EP1171051A4 (en) | Apparatus and method for the processing of solid materials, including hard tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |